Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at ZAR 468.1B, ahead of Eli Lilly (ZAR 360.5B) and Merck & Co (ZAR 318.8B). Figures as of 20 Nov 2026, 12:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonZAR 468.1B
- Median
- -ZAR 834.3M
- Combined market value
- ZAR 65.24T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 468.1B | ZAR 11.23T | ZAR 4,665.39 | 2.04% down | 31% up | ||
| 2 | Eli LillyLLY · Health Care | ZAR 360.5B | ZAR 21.02T | ZAR 23,596.23 | 2.29% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 318.8B | ZAR 5.72T | ZAR 2,319.42 | 3.61% down | 36% up | ||
| 4 | PfizerPFE · Health Care | ZAR 135.7B | ZAR 2.74T | ZAR 480.96 | 1.85% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | ZAR 123.2B | ZAR 2.08T | ZAR 1,018.86 | 2.05% down | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | ZAR 113.9B | ZAR 3.14T | ZAR 1,814.01 | 0.58% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 78.7B | ZAR 1.67T | ZAR 16,125.39 | 2.35% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | ZAR 73.8B | ZAR 8.75T | ZAR 4,951.80 | 0.86% down | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 69B | ZAR 2.31T | ZAR 9,092.91 | 2.94% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | ZAR 46.7B | ZAR 573.3B | ZAR 1,410.93 | 5.59% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | ZAR 23.3B | ZAR 415.8B | ZAR 9,764.23 | 3.16% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | ZAR 13.5B | ZAR 680B | ZAR 1,182.68 | 1.38% down | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | ZAR 11.9B | ZAR 85.1B | ZAR 1,018.60 | 3.16% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | ZAR 7.8B | ZAR 171.3B | ZAR 1,133.08 | 1.88% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 6.1B | ZAR 207.8B | ZAR 1,072.65 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 5.5B | ZAR 345.8B | ZAR 2,581.56 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | ZAR 2.2B | ZAR 100.2B | ZAR 5,011.18 | 3.94% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | ZAR 1.7B | ZAR 124.2B | ZAR 1,134.82 | 4.15% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 1.3B | ZAR 130.2B | ZAR 373.56 | 2.24% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -ZAR 28.5M | ZAR 107.8B | ZAR 762.31 | 1.25% up | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -ZAR 408M | ZAR 108.9B | ZAR 1,668.01 | 3.27% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -ZAR 446.1M | ZAR 81B | ZAR 843.52 | 3.86% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -ZAR 1.2B | ZAR 91.7B | ZAR 2,172.37 | 0.38% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -ZAR 1.4B | ZAR 107.1B | ZAR 2,637.44 | 3.33% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -ZAR 1.8B | ZAR 115.6B | ZAR 1,703.98 | 1.91% up | 233% up | ||
| 26 | ErascaERAS · Health Care | -ZAR 2.2B | ZAR 87.2B | ZAR 248.34 | 3.34% up | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -ZAR 2.3B | ZAR 141.4B | ZAR 2,165.91 | 2.47% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -ZAR 2.7B | ZAR 161.9B | ZAR 1,705.03 | 3.77% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -ZAR 2.8B | ZAR 83.4B | ZAR 1,481.49 | 1.01% up | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -ZAR 2.9B | ZAR 78.7B | ZAR 719.00 | 0.48% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -ZAR 3.2B | ZAR 124.6B | ZAR 2,369.54 | 1.25% up | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -ZAR 3.2B | ZAR 70.5B | ZAR 514.84 | 1.24% up | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -ZAR 3.4B | ZAR 141.4B | ZAR 2,039.82 | 1.88% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -ZAR 4.1B | ZAR 229.5B | ZAR 459.13 | 1.54% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -ZAR 5B | ZAR 161B | ZAR 6,928.75 | 0.34% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -ZAR 5.2B | ZAR 54.5B | ZAR 281.17 | 0.92% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -ZAR 5.3B | ZAR 151.8B | ZAR 5,429.62 | 1.87% up | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -ZAR 5.7B | ZAR 84.3B | ZAR 484.46 | 0.25% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -ZAR 6.7B | ZAR 79.2B | ZAR 475.38 | 0.62% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -ZAR 12.8B | ZAR 266B | ZAR 1,365.35 | 0.22% up | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -ZAR 13.7B | ZAR 125.2B | ZAR 898.71 | 0.27% up | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -ZAR 18.9B | ZAR 147.6B | ZAR 184.60 | 0.67% up | 35% down | ||
| 43 | InsmedINSM · Health Care | -ZAR 22.3B | ZAR 553.5B | ZAR 2,522.88 | 20.58% up | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -ZAR 61.4B | ZAR 398B | ZAR 347.19 | 1.97% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4642 ZAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (ZAR 468.1B), Eli Lilly (ZAR 360.5B) and Merck & Co (ZAR 318.8B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 12:40 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of ZAR 65.24T as of 20 Nov 2026, 12:40 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.